RESUMO
Diabetic retinopathy (DR) is one of the most prevalent secondary complications associated with diabetes. Specifically, Type 1 Diabetes Mellitus (T1D) has an immune component that may determine the evolution of DR by compromising the immune response of the retina, which is mediated by microglia. In the early stages of DR, the permeabilization of the blood-retinal barrier allows immune cells from the peripheral system to interact with the retinal immune system. The use of new bioactive molecules, such as 3-(2,4-dihydroxyphenyl)phthalide (M9), with powerful anti-inflammatory activity, might represent an advance in the treatment of diseases like DR by targeting the immune systems responsible for its onset and progression. Our research aimed to investigate the molecular mechanisms involved in the interaction of specific cells of the innate immune system during the progression of DR and the reduction in inflammatory processes contributing to the pathology. In vitro studies were conducted exposing Bv.2 microglial and Raw264.7 macrophage cells to proinflammatory stimuli for 24 h, in the presence or absence of M9. Ex vivo and in vivo approaches were performed in BB rats, an animal model for T1D. Retinal explants from BB rats were cultured with M9. Retinas from BB rats treated for 15 days with M9 via intraperitoneal injection were analyzed to determine survival, cellular signaling, and inflammatory markers using qPCR, Western blot, or immunofluorescence approaches. Retinal structure images were acquired via Spectral-Domain-Optical Coherence Tomography (SD-OCT). Our results show that the treatment with M9 significantly reduces inflammatory processes in in vitro, ex vivo, and in vivo models of DR. M9 works by inhibiting the proinflammatory responses during DR progression mainly affecting immune cell responses. It also induces an anti-inflammatory response, primarily mediated by microglial cells, leading to the synthesis of Arginase-1 and Hemeoxygenase-1(HO-1). Ultimately, in vivo administration of M9 preserves the retinal integrity from the degeneration associated with DR progression. Our findings demonstrate a specific interaction between both retinal and systemic immune cells in the progression of DR, with a differential response to treatment, mainly driven by microglia in the anti-inflammatory action. In vivo treatment with M9 induces a switch in immune cell phenotypes and functions that contributes to delaying the DR progression, positioning microglial cells as a new and specific therapeutic target in DR.
Assuntos
Diabetes Mellitus Tipo 1 , Retinopatia Diabética , Modelos Animais de Doenças , Microglia , Animais , Retinopatia Diabética/tratamento farmacológico , Retinopatia Diabética/patologia , Retinopatia Diabética/imunologia , Ratos , Diabetes Mellitus Tipo 1/tratamento farmacológico , Diabetes Mellitus Tipo 1/imunologia , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/complicações , Camundongos , Microglia/efeitos dos fármacos , Microglia/metabolismo , Retina/efeitos dos fármacos , Retina/patologia , Retina/metabolismo , Células RAW 264.7 , Masculino , Benzofuranos/farmacologia , Benzofuranos/uso terapêutico , Imunomodulação/efeitos dos fármacos , Inflamação/tratamento farmacológico , Inflamação/patologia , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/complicações , Ratos Endogâmicos BBRESUMO
Abstract Norepinephrine in the basolateral amygdala (BLA) plays a pivotal role in mediating the effects of stress on memory functions in the hippocampus, however, the functional contribution of β1-adrenergic receptors on the BLA inputs to the CA1 region of hippocampus and memory function are not well understood. In the present study the role of β1-adrenoreceptor in the BLA on memory, neuronal arborization and long-term potentiation (LTP) in the CA1 region of hippocampus was examined by infusion the β1-adrenoreceptor agonist (Dobutamine; 0.5µl/side) or antagonist (Atenolol; 0.25µL/side) bilaterally into the BLA before foot-shock stress. Passive avoidance test results showed that Step-through latency time was significantly decreased in the stress group rats one, four and seven days after the stress, which intra-BLA injection of Atenolol or Dobutamine before stress couldn't attenuate this reduction. Barnes-maze results revealed that infusion of Dobutamine and Atenolol significantly reduced spatial memory indicators such as increased latency time, the number of errors and the distance traveling to achieve the target hole in the stress group. These learning impairments in stress rats correlated with a reduction of LTP in hippocampal CA1 synapses in-vivo, which infusion of Dobutamine and Atenolol couldn't attenuate the population spike amplitude and mean-field excitatory postsynaptic potentials (fEPSP) slope reduction induced by stress. Also, the Golgi-Cox staining demonstrated that infusion of Atenolol attenuated stress decreased CA1 region dendritic and axonal arborization. These results suggest that β1-adrenergic receptors activation or block seem to exacerbate stress-induced hippocampal memory deficits and this effect is independent of CA1 LTP modulation.
Assuntos
Animais , Masculino , Ratos , Estresse Fisiológico/efeitos dos fármacos , Norepinefrina/metabolismo , Dobutamina/farmacologia , Região CA1 Hipocampal/efeitos dos fármacos , Agonistas de Receptores Adrenérgicos beta 1/farmacologia , Complexo Nuclear Basolateral da Amígdala/efeitos dos fármacos , Plasticidade Neuronal/efeitos dos fármacos , Ratos Endogâmicos BB , Hipocampo/efeitos dos fármacosRESUMO
To evaluate the effects of parathyroid hormone (PTH) on urinary acidification parameters, thyroparathyroidectomy was performed in normal (TPTX) and in calcium-supplemented rats (TPTX+Ca2**). Both groups were supplemented with thyroxin. Glomerular filtration rate (GFR) fell from 7.79 ñ 0.33 in the control group (C) to 4.88 ñ 0.26 ml min**-1Kg**-1 in TPTX, while net acid excretion fell from 5.65 ñ 0.22 in C to 3.76 ñ 0.26 µmol min**1Kg in TPTX. Kinetic dat of urinary acidification obtained by microperfusion techniques in proximal tubules showed that the half-time of acidification (t/2) rose from 4.75 ñ 0.24 s in C to 8.97 ñ 0.64s in TPTX and persisted elevated in TPTx +Ca**2+ (7.40 ñ 0.43s); in the latter group, stationary pH was not significantly different from that of the control group. Bicarbonate reabsorption (J**HCO3) fell from 2.18 ñ 0.15 in C to 0.823 ñ 0.082 in TPTX and was 1.53 ñ 0.073 nmol s**-1 cm**-2 in TPTX+Ca**2+. These suggest that normal pH gradients depend on normal calcium levels, but acidification half-times are dependent on PTH, which also contributes keeping glomerular hemodynamics and acidification rates at normal levels
Assuntos
Animais , Masculino , Ratos , Acidose/etiologia , Bicarbonatos/urina , Rim/fisiopatologia , Hormônio Paratireóideo/farmacologia , Ratos Endogâmicos BBRESUMO
En este trabajo los autores se propusieron comprobar que el elevado contenido de compuestos polifenólicos en el grano de sorgo (Sorghum saccharatum, var. sugar drip) ejerce una influencia desfavorable sobre la absorción nitrogenada. Para arribar a esta conclusión, se disminuyó el contenido de taninos de la harina de sorgo mediante tratamiento con polivinilpirrolidona (PVP), como complejante. Se realizaron experiencias biológicas con harina sin tratamiento (S), y tratada con PVP (S + PVP). El tratamiento mejoró la digestibilidad verdadera (D), obteniéndose los valores P < 0.01). La valoración de taninos arrojó estos resultados: S = 1.90g/100g, y S + PVP = 0.85g/100g, informados como ácido tánico. El aumento de digestibilidad se tradujo en un mejor aprovechamiento nitrogenado, siendo los valores de utilización proteínica neta (NPU) para S y S + PVP de 19 ñ 1.58 y 37 + 3.36, respectivamente (significación P < 0.001)